Encompass Health Corporation Stock

Equities

EHC

US29261A1007

Healthcare Facilities & Services

Market Closed - Nyse 16:00:04 2024-07-12 EDT 5-day change 1st Jan Change
86.54 USD +0.75% Intraday chart for Encompass Health Corporation +1.51% +29.71%
Sales 2024 * 5.31B 7.24B Sales 2025 * 5.78B 7.88B Capitalization 8.71B 11.88B
Net income 2024 * 416M 567M Net income 2025 * 465M 634M EV / Sales 2024 * 2.1 x
Net Debt 2024 * 2.42B 3.3B Net Debt 2025 * 2.14B 2.92B EV / Sales 2025 * 1.88 x
P/E ratio 2024 *
21.4 x
P/E ratio 2025 *
19.4 x
Employees 27,209
Yield 2024 *
0.69%
Yield 2025 *
0.69%
Free-Float 85.67%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.75%
1 week+1.51%
Current month+0.87%
1 month+2.66%
3 months+7.52%
6 months+25.53%
Current year+29.71%
More quotes
1 week
83.68
Extreme 83.68
87.59
1 month
83.21
Extreme 83.21
87.59
Current year
65.99
Extreme 65.99
87.94
1 year
57.55
Extreme 57.55
87.94
3 years
44.33
Extreme 44.33
87.94
5 years
44.33
Extreme 44.33
89.68
10 years
30.26
Extreme 30.26
89.68
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 92-12-31
Director of Finance/CFO 62 10-05-05
Chief Tech/Sci/R&D Officer 64 -
Members of the board TitleAgeSince
Director/Board Member 69 13-01-24
Chairman 62 19-12-31
Director/Board Member 68 21-09-30
More insiders
Date Price Change Volume
24-07-12 86.54 +0.75% 482,385
24-07-11 85.9 +1.33% 1,038,798
24-07-10 84.77 +0.95% 503,386
24-07-09 83.97 0.00% 412,600
24-07-08 83.97 -1.50% 478,083

Delayed Quote Nyse, July 12, 2024 at 04:00 pm

More quotes
Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides specialized rehabilitative treatment on an inpatient basis. It operates hospitals in 37 states and Puerto Rico, with concentrations in Florida and Texas. It operates 161 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. The Company provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals also treat patients with or recovering from the COVID-19 virus. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
86.54 USD
Average target price
98.09 USD
Spread / Average Target
+13.35%
Consensus